Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

These CENP-A proteins ensure that divided genetic information is kept intact during mitosis.

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good morning, and welcome to Hyzon’s Third Quarter 2024 Earnings ...

Samsung Black Friday deals are officially here! If you want to snag one of the best Samsung phones, smartwatches, tablets or ...

However, the biggest battery maker in the world, Contemporary Amperex Technology Limited, better known as CATL, believes that ...

The Commerce Commission takes One NZ to court over representations made in its campaign promoting “100% mobile coverage”.

The future of Africa’s smartphone market depends on multi-stakeholder collaboration, according to delegates at AfricaCom 2024 ...

A Falcon 9 rocket carrying 20 Starlink spacecraft, including 13 with direct-to-cell capability, is scheduled to lift off from ...

IOL sat down with Todd Ashton, Vice President and Head of Customer Unit South and East Africa for Ericsson at the Africa Tech ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and ...

Solidigm is a pioneer of QLC (quad-level cell), which means four bits per cell, the highest density of SSD storage available.